Report ID: SQMIG35A2184
Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Infusion Pump Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Infusion Pump industry players.
The global infusion pump market is expected to grow 1.7 times soon because of enhanced healthcare infrastructure, increased focus on chronic disease management, and the rising demand for innovative drug delivery technology globally. Manufacturers have increasingly fast-tracked their research and development programs to grow viable infusion systems that are safer, smarter, and more reliable due to the rapid nature of the market. However, among the major issues hindering such widespread acceptance are high operational costs of advanced equipment and regulatory compliance. This page looks at the strategic maneuvers the players have undertaken to augment their competitive advantage in infusion pump markets.
According to SkyQuest Technology “Infusion Pump Market By Product Type (Volumetric Infusion Pumps, Syringe Infusion Pumps, Patient-Controlled Analgesia Pumps, Enteral Infusion Pumps, and Insulin Infusion Pumps) By Application, By End User, By Region - Industry Forecast 2025-2032,” with inflated numbers of individuals developing cancer and requiring continuous, precise chemotherapy, oncology will become the fastest growing category of infusion pumps worldwide.
|
Company |
Est. Year |
Headquarters |
Revenue |
Key Services |
|
Becton, Dickinson and Company (BD) |
1897 |
Franklin Lakes, New Jersey, USA |
Global revenue USD 20.2 B in FY2021; infusion-pump business strong in 2024 (Alaris line) |
Designs, manufactures and markets infusion pumps (volumetric, syringe, PCA) and associated disposables; supplies hospitals and home-care; integrates pump systems into drug-delivery & infusion-therapy workflows. |
|
B. Braun Melsungen SE |
1839 |
Melsungen, Germany |
USD 9.45 Billion (2023) |
Offers volumetric and syringe infusion pumps under Infusomat and Space lines; delivers smart pump software, infusion safety systems and hospital fluid-therapy accessories; global footprint in critical care. |
|
Baxter International Inc. |
1931 |
Deerfield, Illinois, USA |
USD 10.64 Billion (2024) |
Supplies infusion pumps and devices for IV therapy, haemophilia, renal and surgical care; strong demand for infusion pumps noted in 2024 earnings. |
|
Terumo Corporation |
1921 |
Tokyo, Japan |
USD 6.07 Billion (2023) |
Manufactures infusion sets, syringe and volumetric pumps, IV systems; focuses on cardiovascular and general hospital business; global distribution. |
|
Fresenius Kabi AG (part of Fresenius) |
1912 (group) |
Bad Homburg, Germany |
Group revenue USD 24.08 billion (2023) |
Offers infusion pumps, infusion therapy solutions, IV drugs and clinical nutrition; provides devices for hospitals and home-care settings. |
|
Medtronic plc |
1949 |
Dublin, Ireland |
USD 32.364 Billion (2024) |
While primarily known for cardiovascular devices, also markets infusion pumps (insulin and drug delivery) and related digital health platforms. |
|
ICU Medical Inc. |
1984 |
San Clemente, California, USA |
USD 629.8 Million (2024) |
Produces infusion pumps, IV management systems, closed-system transfer devices, sensors and monitoring accessories focused on safety and critical-care infusion. |
|
Smiths Medical Group Ltd. |
1851 (Smiths Group) |
London, UK (division) |
- |
Offers infusion and syringe pumps, ambulatory infusion systems, patient-controlled analgesia solutions, and home-infusion devices. |
|
Nipro Corporation |
1954 |
Osaka, Japan |
- |
Manufactures medical devices including infusion pumps, catheter systems and IV therapy equipment, with global export focus. |
|
Ypsomed Holding AG |
2003 |
Burgdorf, Switzerland |
USD 619.76 Million (2024) |
Specialises in infusion and injection systems for self-medication (not large hospital pumps) – insulin pumps and infusion sets for chronic disease management in home-care settings. |
With its ubiquitous infusion systems, Alaris product line, BD has always had a significant position in the infusion pump market. To significantly decrease prescription errors, the company is aspiring to standardize drug libraries, interconnect smart pumps, and ensure collaboration among hospitals. Health-care facilities can now harness the ability of BD analytic solutions to help inventory their infusion operations in an efficient and safe manner. Even more, BD became a leader in delivering then few high magnesium infusion delivery solutions by further strengthening its ability to address software recalls plus infusion safety enhancements.
The Infusomat Space and Perfusor Space pumps of B. Braun are acknowledged for accurately delivering medication, dimensions-small, ease of integration with other devices. The company continues to step up the integration of its wireless fleet management, closed-loop prevention of medication errors, and drug library integration. B. Braun is strongly present with manufacturing and training infrastructure to support large hospital networks across the globe. By further dilating its digital infusion therapy systems and internationally making them available, the company gained prominence in enhancing safety and consistency of infusion in clinical settings.
The demands and expectations of infusion therapy worldwide have been met by Baxter's Spectrum IQ pumps in matters of accuracy and integration with other devices. The company has put the stress on integration with hospital EHR systems, barcode verification of drugs, and enhanced interoperability.The sales of infusion systems in North America remain strong, says Baxter in its 2024 results. The companies also would rather invest in developing their cloud-based analytics and enhancements in cybersecurity contributing to safer and more effective drug delivery in acute care settings. This is what keeps the business relevant on the global market.
Terumo is relevant as its syringe pumps, volumetric pumps, infusion sets, and IV systems find frequent usage in hospitals of Asia, Europe, and the USA. Its pumps focus on delivering medications with utmost precision for critical care, surgeries, and oncology. Terumo keeps improving the safety alerts and wireless communication to minimize errors occurring during the infusion. The company extended the reach of its smart infusion systems; thus, it was able to support high-acuity clinical workflows and enhanced its footprint into new territories.
The overall infusion pump market gets strengthened by the Fresenius Kabi Agilia pump platform which is applicable for both volumetric and syringe application. As this company emphasizes safety, adaptability, and user-friendliness in clinical settings, its pumps enjoy broad acceptance at home and hospital settings. Combined with their therapeutic pump solutions, Fresenius Kabi utilizes digital monitoring tools to enhance precise infusion delivery and assist the patient with adherence to the treatment plan. It further successively expanded intravenous drug-pump ecosystems to ameliorate drug interactions and support the delivery of integrated infusion therapy.
Since Medtronic is global infusion therapy development for diabetes, then its MiniMed insulin pumps automatically inject insulin more reliably with glucose for medication management. The company continues to innovate with wearable, vending, and connected pump systems that contribute to the recovery of people suffering from chronic diseases. Medtronic infused new AI-moving insulin dose algorithms, and hybrid closed-loop devices were made widely available to users. Other technological formats on infusion pump developments were affected by this.
By creating advanced infusion pumps, IV sets, and closed-system transfer devices to enhance drug delivery safety, ICU Medical has made a large contribution. In entering the Smiths Medical acquisition, the company also extended into product lines of high-acuity infusion systems, ambulatory pumps, and syringe pumps. Cybersecurity and minimizing dosage errors and safety are the top areas of concern for ICU Medical. The addition of intelligent monitoring technology to its platforms cemented the company's absorption into the leadership status surrounding critical-care infusion safety.
A significant entity before absorbing into ICU Medical, Smiths Medical- Medfusion syringe pumps, CADD ambulatory pumps, and home-infusion solutions. Because of their precision and compactness, these devices are still widely employed in pain management, anesthesia, and pediatrics. Manufacturing robust, durable, and compact pumps, the company drove ambulatory infusion market. Its innovations continue to add to ICU Medical products and improve the safety of infusion therapy in clinical and home settings.
Nipro supports the infusion pump market by making a variety of infusion systems, IV therapy equipment, and catheter technologies. The company has found great successes in Asia and Latin America, where the demand for reliable and affordable infusion solutions is high. The firm specializes in creating durable and easy-to-operate devices compatible with various medical supply. The company has further advanced the worldwide expansion of its manufacture and distribution capacities, thus enhancing the availability of vital infusion treatment technology for the practitioners.
Ypsomed has a unique position in the management of diabetes due to its highly sophisticated insulin delivery and infusion technology. The small YpsoPump platform has user-friendly digital interfaces and can interface with continuous glucose monitoring devices. The company is focused on making pumps that are easy for patients to operate and help with their therapy. The partnership with a growing number of digital health companies enhanced connectivity features and contributed to the modernization of ambulatory infusion therapy for chronic illness patients around the world.
With the incorporation of smart pump ecosystems and interoperability features from major players like BD, Baxter, B. Braun, and Fresenius Kabi, the infusion pump industry will continue to thrive. Medtronic and Ypsomed are busy innovating around infusion platforms either in the context of wearables or with diabetes, while ICU Medical and Smiths Medical pursue developments on the safety aspects of relevant solutions. Affordable yet highly accurate, Terumo and Nipro guarantee and ensure that concerning absolute essentials, this commodity is there for all. All this makes possible the process of incorporating digital technology, propelled forward by these emerging innovators together with these well-known names, toward transferring the entire global market to safer, better connected, and patient-centered infusion therapy solutions.
REQUEST FOR SAMPLE
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35A2184
sales@skyquestt.com
USA +1 351-333-4748